COMMUNIQUÉS West-GlobeNewswire

Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences
09/04/2026
SAN DIEGO, April 09, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]
Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect
09/04/2026
The addition of Foundayo® (orforglipron) gives Weight Watchers Med+ members a new FDA-approved oral GLP-1 option for weight loss NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight [...]
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Siemens Healthineers for the Transformative Bio-Hermes-002 Study
09/04/2026
Siemens Healthineers joins collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer's disease and dementias WASHINGTON, April 09, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform [...]
MMI Introduces World’s First Microsurgical Suture for Robotics
09/04/2026
New suture expands the Symani ecosystem, supporting greater efficiency and precision in robotic microsurgery JACKSONVILLE, Fla., April 09, 2026 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics [...]
Imprivata Appoints Cindy Zhou as Chief Marketing Officer
09/04/2026
Award-winning cybersecurity marketing executive brings extensive experience in leading high-impact teams to elevate Imprivata’s global market leadership WALTHAM, Mass., April 09, 2026 (GLOBE NEWSWIRE) -- Imprivata , a [...]
Sonablate Expands Leadership to Accelerate Growth in Incision-Free Prostate Care Solutions
09/04/2026
Appointments support rising demand for HIFU and advance the “precision sound medicine” platform across new clinical applications CHARLOTTE, N.C., April 09, 2026 (GLOBE NEWSWIRE) -- Sonablate , a global leader in focused [...]
Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting
09/04/2026
SALT LAKE CITY, April 09, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that it will share new data at the Society of [...]
Cardiology Consultants of Philadelphia Launches CCP Now, a Specialized Cardiac Walk-In Facility in Delaware County
09/04/2026
SPRINGFIELD, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Cardiology Consultants of Philadelphia (CCP), the region’s leading cardiology practice, today announced the grand opening of CCP Now, a cardiac walk-in facility [...]
The Science Behind Glycocalyx Support: Why Rhamnan Sulfate Is Different
09/04/2026
Rhamnan sulfate is a marine-derived polysaccharide specifically studied for its structural affinity to the endothelial glycocalyx, the lining inside every blood vessel. Calroy holds patents on microfluidic chip [...]
Cures Within Reach Approves Five Clinical Trials at Chicago-based Research Institutions
09/04/2026
Clinical trials are led by early-stage investigators and/or impact health equity, veterans and pediatrics Future funding increased to offset cuts in medical research funding CHICAGO, April 09, 2026 (GLOBE NEWSWIRE) -- [...]
Çakırtepe Hospital Performs Its First UBE Spine Surgery in Ünye
09/04/2026
ÜNYE, Türkiye, April 09, 2026 (GLOBE NEWSWIRE) -- Çakırtepe Hospital , located on Türkiye’s Black Sea coast in Ünye, has achieved a new milestone in advanced spine care by performing its first UBE (Unilateral Biportal [...]
Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth
09/04/2026
• Adam Schayowitz, Ph.D., MBA appointed as Head of R&D • Scott Platshon appointed as Chief Business Officer VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a [...]
C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)
09/04/2026
Agreement Focused on Developing DACs With Payloads For Two Oncology Targets, With an Option for a Third Target C4T to Develop Degraders With Payload Properties; Roche to Conjugate Payloads to Targeted Antibodies C4T to [...]
Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer
09/04/2026
TORONTO and HOUSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of [...]
Nkarta to Participate in Needham Virtual Healthcare Conference
09/04/2026
SOUTH SAN FRANCISCO, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune [...]
Seres Therapeutics to Present at CARB-X Investor Day
09/04/2026
CAMBRIDGE, Mass., April 09, 2026 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading live biotherapeutics company, today announced that it will present at the 2026 CARB-X [...]
Netramark-Authored, Peer-Reviewed Article Suggests Psychedelics Might Not Only Affect Brain Chemistry, They May Also Involve Quantum-Level Processes Inside the Brain
09/04/2026
Publication strengthens NetraMark's case for biomarker-guided enrichment, individualized response modeling, and explainable AI for trial design in psychedelic clinical development. TORONTO, April 09, 2026 (GLOBE [...]
Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate
09/04/2026
KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate Option exercise of KT-200 triggers a $45 million milestone payment to Kymera from Gilead Sciences WATERTOWN, Mass., April 09, 2026 ( [...]
Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference
09/04/2026
TORONTO, April 09, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“ Satellos ” or the “ Company ”), a clinical-stage biotechnology company developing life-improving medicines to treat [...]

Pages